Egypt’s Abu Al-Naga family brings in North Africa investor RMBV for 50% of ATCO Pharma in reported $50 million deal

Egypt’s Abu Al-Naga family brings in North Africa investor RMBV for 50% of ATCO Pharma in reported $50 million deal

North Africa-focused investment firm RMBV has agreed to invest in Egypt’s ATCO Pharma, in a transaction reported to be worth $50 million for a 50% stake in the family-controlled pharmaceutical company.

Comment